A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders

• Published in: Frontiers in cellular neuroscience 2015-07, Vol.9, p.280-280
• Main Authors: Reinhard, Sarah M, Razak, Khaleel, Ethell, Iryna M
• Format: Article
• Language: English
• Subjects: Axon guidance; Axonal plasticity; Brain; Cell adhesion & migration; Cell surface; Central nervous system; Cerebellum; Circuits; critical period; Cytokines; Developmental plasticity; Epilepsy; Extracellular Matrix; Fragile X Syndrome; Gelatinase B; Hippocampus; Insulin-like growth factors; Intellectual disabilities; Matrix metalloproteinase; Metalloproteinase; Multiple sclerosis; Myelination; Neural networks; Neurodegenerative diseases; Neurodevelopmental disorders; Neuroscience; Pathophysiology; Plasticity (neural); Proteins; Synaptic plasticity; Synaptogenesis; Transgenic animals; Traumatic brain injury
• ISSN: 1662-5102; 1662-5102
• DOI: 10.3389/fncel.2015.00280

The extracellular matrix (ECM) is a critical regulator of neural network development and plasticity. As neuronal circuits develop, the ECM stabilizes synaptic contacts, while its cleavage has both permissive and active roles in the regulation of plasticity. Matrix metalloproteinase 9 (MMP-9) is a member of a large family of zinc-dependent endopeptidases that can cleave ECM and several cell surface receptors allowing for synaptic and circuit level reorganization. It is becoming increasingly clear that the regulated activity of MMP-9 is critical for central nervous system (CNS) development. In particular, MMP-9 has a role in the development of sensory circuits during early postnatal periods, called 'critical periods.' MMP-9 can regulate sensory-mediated, local circuit reorganization through its ability to control synaptogenesis, axonal pathfinding and myelination. Although activity-dependent activation of MMP-9 at specific synapses plays an important role in multiple plasticity mechanisms throughout the CNS, misregulated activation of the enzyme is implicated in a number of neurodegenerative disorders, including traumatic brain injury, multiple sclerosis, and Alzheimer's disease. Growing evidence also suggests a role for MMP-9 in the pathophysiology of neurodevelopmental disorders including Fragile X Syndrome. This review outlines the various actions of MMP-9 during postnatal brain development, critical for future studies exploring novel therapeutic strategies for neurodevelopmental disorders.